| | | | | 1 | | | |
| | | | | | | ||
| | | | | | | ||
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | | | ||
| | | | | A-1 | | |
Name | | | Year Initially Elected | | | Age(1) | | | Position(s) | | | Expiration of Term | | | Class | |
Dov A. Goldstein, M.D.(2) | | | 2019 | | | 54 | | | Director | | | 2024 | | | I | |
Gerry J. McDougall(3)(4) | | | 2021 | | | 55 | | | Director | | | 2022 | | | II | |
Franklyn G. Prendergast, M.D., Ph.D.(2)(4) | | | 2019 | | | 77 | | | Director | | | 2023 | | | III | |
Eric I. Richman(2)(3)(4) | | | 2019 | | | 61 | | | Director | | | 2024 | | | I | |
Dietrich Stephan, Ph.D | | | 2019 | | | 52 | | | Chairman, President and Chief Executive Officer | | | 2022 | | | II | |
Eric Ende, M.D(3)(4) | | | 2022 | | | 54 | | | Director | | | 2023 | | | III | |
Name | | | Year Initially Elected | | | Age(1) | | | Position(s) | | | Expiration of Term | | | Class | |
Dov A. Goldstein, M.D.(2) | | | 2019 | | | 55 | | | Chairperson | | | 2024 | | | I | |
Gerald J. McDougall(3)(4) | | | 2021 | | | 56 | | | Director | | | 2025 | | | II | |
Franklyn G. Prendergast, M.D., Ph.D.(2)(4) | | | 2019 | | | 78 | | | Director | | | 2023 | | | III | |
Eric I. Richman(2)(3)(4) | | | 2019 | | | 62 | | | Director | | | 2024 | | | I | |
Dietrich A. Stephan, Ph.D. | | | 2019 | | | 53 | | | Chief Executive Officer and Director | | | 2025 | | | II | |
Gender | | | Female | | | Male | | ||||||
Number of Directors based on gender identity | | | | | 0 | | | | | | 5 | | |
Number of Directors Who Self-Identify In any Category Below | | | | | | | | | | | | | |
African American or Black | | | | | 0 | | | | | | 0 | | |
Hispanic or Latinx | | | | | 0 | | | | | | 0 | | |
White or Caucasian | | | | | 0 | | | | | | 4 | | |
Asian | | | | | 0 | | | | | | 0 | | |
LGBQT+ | | | | | 0 | | | | | | 0 | | |
Information not provided | | | | | 0 | | | | | | 1 | | |
Gender | | | Female | | | Male | | ||||||
Number of Directors based on gender identity | | | | | 0 | | | | | | 6 | | |
Number of Directors Who Self-Identify In any Category Below | | | | | | | | | | | | | |
African American or Black | | | | | 0 | | | | | | 0 | | |
Hispanic or Latinx | | | | | 0 | | | | | | 0 | | |
White or Caucasian | | | | | 0 | | | | | | 5 | | |
Asian | | | | | 0 | | | | | | 0 | | |
LGBQT+ | | | | | 0 | | | | | | 0 | | |
Information not provided | | | | | 0 | | | | | | 1 | | |
| | 2021 | | 2020 | | | 2022 | | 2021 | | ||||||||||||||||
Audit Fees(1): | | | $ | 272,950 | | | | $ | 455,620 | | | | | $ | 322,650 | | | | $ | 272,950 | | | ||||
Audit-Related Fees(2): | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
Tax Fees(3): | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
All Other Fees(4): | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
Total All Fees: | | | $ | 272,950 | | | | $ | 455,620 | | | | | $ | 322,650 | | | | $ | 272,950 | | |
| | | Pre-Reverse Split | | | Post-Reverse Split | | ||||||||||||||||||||||||
| 5:1 | | | 10:1 | | | 15:1 | | | 20:1 | | ||||||||||||||||||||
Authorized | | | | | 250,000,000 | | | | | | 250,000,000 | | | | | | 250,000,000 | | | | | | 250,000,000 | | | | | | 250,000,000 | | |
Outstanding | | | | | (32,258,657) | | | | | | (6,451,731) | | | | | | (3,225,866) | | | | | | (2,150,577) | | | | | | (1,612,933) | | |
Reserved for future issuance pursuant to employee benefit plans | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Reserved for future issuance pursuant to outstanding options | | | | | (8,360,896) | | | | | | (1,672,179) | | | | | | (836,090) | | | | | | (557,393) | | | | | | (418,045) | | |
Reserved for future issuance pursuant to outstanding warrants | | | | | (180,000) | | | | | | (36,000) | | | | | | (18,000) | | | | | | (12,000) | | | | | | (9,000) | | |
Authorized but unissued and unreserved | | | | | 209,200,447 | | | | | | 241,840,089 | | | | | | 245,920,045 | | | | | | 247,280,030 | | | | | | 247,960,022 | | |
Name | | | Age | | | Position | |
Dietrich A. Stephan, Ph.D. | | | | | Chief Executive Officer and Director | | |
Todd P. Branning | | | | | Chief Financial Officer and Secretary | | |
Name and Position | | Year | | Salary | | Bonus(1) | | Option Awards(2) | | Non-Equity Incentive Plan Compensation | | All Other Compensation(3) | | Total | | | Year | | Salary | | Bonus(1) | | Stock Awards | | Option Awards(2) | | Non-Equity Incentive Plan Compensation | | All Other Compensation(3) | | Total | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich Stephan, Ph.D., Chief Executive Officer | | | | | 2021 | | | | $ | 469,149 | | | | $ | 196,875 | | | | $ | 799,886 | | | | $ | — | | | | $ | 47,808 | | | | $ | 1,513,717 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | $ | 441,346 | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | 47,475 | | | | $ | 488,821 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sam Backenroth, Former Chief Financial Officer | | | | | 2021 | | | | $ | 363,462 | | | | $ | 140,000 | | | | $ | 639,023 | | | | $ | — | | | | $ | 23,330 | | | | $ | 1,165,814 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | $ | 320,000 | | | | $ | 20,000 | | | | $ | — | | | | $ | — | | | | $ | 18,524 | | | | $ | 358,524 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
William Mann, Ph.D., Chief Operating Officer (4) | | | | | 2021 | | | | $ | 381,923 | | | | $ | 62,500 | | | | $ | 61,750 | | | | $ | — | | | | $ | 25,975 | | | | $ | 532,149 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | $ | 57,692 | | | | $ | 45,000 | | | | $ | 917,000 | | | | $ | — | | | | $ | 3,663 | | | | $ | 1,023,355 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich A. Stephan, Chief Executive Officer | | | | | 2022 | | | | $ | 536,798 | | | | $ | 247,000 | | | | $ | — | | | | $ | 318,240 | | | | $ | — | | | | $ | 52,782 | | | | $ | 1,154,820 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | 469,149 | | | | $ | 196,875 | | | | $ | — | | | | $ | 799,886 | | | | $ | — | | | | $ | 47,808 | | | | $ | 1,513,718 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Todd P. Branning, Chief Financial Officer | | | | | 2022 | | | | $ | 310,577 | | | | $ | — | | | | $ | — | | | | $ | 495,000 | | | | $ | — | | | | $ | 13,446 | | | | $ | 819,023 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||
William R. Mann, Ph.D., Former President and Chief Operating Officer (4) | | | | | 2022 | | | | $ | 422,221 | | | | $ | 168,000 | | | | $ | — | | | | $ | 62,587 | | | | $ | — | | | | $ | 30,111 | | | | $ | 682,919 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | 381,923 | | | | $ | 62,500 | | | | $ | — | | | | $ | 61,750 | | | | $ | — | | | | $ | 25,975 | | | | $ | 532,148 | | |
Name | | Year | | 401(k) Company | | Group Term | | Health Benefits | | Life Insurance | | Paid Time Off Buy Back | | Total Other Compensation | | | Year | | 401(k) Company | | Group Term | | Health Benefits | | Life Insurance | | Paid Time Off Buy Back | | Total Other Compensation | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich Stephan, Ph.D. Chief Executive Officer | | | | | 2021 | | | | | — | | | | $ | — | | | | $ | 25,716 | | | | $ | 22,092 | | | | | — | | | | $ | 47,808 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | | — | | | | $ | — | | | | $ | 21,761 | | | | | 25,714 | | | | | — | | | | $ | 47,475 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sam Backenroth Former Chief Financial Officer | | | | | 2021 | | | | | 1,283 | | | | $ | 420 | | | | $ | 21,627 | | | | | — | | | | | — | | | | $ | 23,330 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | | — | | | | $ | — | | | | $ | 18,524 | | | | | — | | | | | — | | | | $ | 18,524 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||
William Mann, Ph.D. Chief Operating Officer | | | | | 2021 | | | | | — | | | | $ | 454 | | | | $ | 25,522 | | | | | — | | | | | — | | | | $ | 25,976 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2020 | | | | | — | | | | $ | — | | | | | 3,663 | | | | | — | | | | | — | | | | $ | 3,663 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich A. Stephan, Ph.D. Chief Executive Officer | | | | | 2022 | | | | $ | 10,694 | | | | $ | — | | | | $ | 18,155 | | | | $ | 23,933 | | | | | — | | | | $ | 52,782 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | — | | | | $ | — | | | | $ | 25,716 | | | | | 22,092 | | | | | — | | | | $ | 47,808 | | | |||||||||||||||||||||||||||||||||||||||||||||||||||
Todd P. Branning Chief Financial Officer | | | | | 2022 | | | | $ | 7,356 | | | | $ | 439 | | | | $ | 5,651 | | | | | — | | | | | — | | | | $ | 13,446 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | — | | | | $ | — | | | | $ | — | | | | | — | | | | | — | | | | $ | — | | | |||||||||||||||||||||||||||||||||||||||||||||||||||
William R. Mann, Ph.D. Former President and Chief Operating Officer | | | | | 2022 | | | | $ | 8,287 | | | | $ | 684 | | | | $ | 21,140 | | | | | — | | | | | — | | | | $ | 30,111 | | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2021 | | | | $ | — | | | | $ | 454 | | | | | 25,222 | | | | | — | | | | | — | | | | $ | 25,676 | | |
| | Option Awards | | Stock Awards | | | Option Awards | | Stock Awards | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name | | Number of Securities Underlying Unexercised Options Exercisable (#) | | Number of Securities Underlying Unexercised Options Non- Exercisable (#) | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) | | Option Exercise Price ($) | | Option Expiration Date(1) | | Number of Shares or Units of Stock That Have Not Vested (#) | | Market Value of Shares or Units of Stock That Have Not Vested ($) | | Equity Incentive Plan Awards: Number of Unearned shares, Units or Other Rights That Have Not Vested (#) | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) | | | Number of Securities Underlying Unexercised Options Exercisable (#) | | Number of Securities Underlying Unexercised Options Non- Exercisable (#) | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) | | Option Exercise Price ($) | | Option Expiration Date | | Number of Shares or Units of Stock That Have Not Vested (#) | | Market Value of Shares or Units of Stock That Have Not Vested ($) | | Equity Incentive Plan Awards: Number of Unearned shares, Units or Other Rights That Have Not Vested (#) | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich Stephan, Ph.D. | | | | 3,311,930 | | | | | | | | | | — | | | | $ | 0.001 | | | | | 12/31/2028 | | | | | — | | | | | — | | | | | — | | | | $ | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sam Backenroth | | | | 772,923(2) | | | | | | | | | | — | | | | $ | 5.39 | | | | | 7/12/2029 | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dietrich A. Stephan, Ph.D. | | | | 125,984 | | | | | — | | | | | — | | | | $ | 0.022 | | | | | 12/31/2023(1) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | 17,500(3) | | | | | | | | | | — | | | | $ | 13.40 | | | | | 3/31/2024 | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | 3,608 | | | | | 4,638(2) | | | | | — | | | | $ | 138.40 | | | | | 12/29/2030(4) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||
William Mann, Ph.D. | | | | 51,041 | | | | | 123,959(4) | | | | | — | | | | $ | 7.46 | | | | | 7/27/2030 | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | 25,000(5) | | | | | | | | | $ | 3.46 | | | | | 8/19/2031 | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | 15,300(3) | | | | | — | | | | $ | 31.60 | | | | | 1/24/2032(4) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||
Todd P. Branning | | | | — | | | | | 15,000(5) | | | | | — | | | | $ | 50.40 | | | | | 1/10/2032(4) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
William R. Mann, Ph.D. | | | | 4,740 | | | | | 4,010(6) | | | | | — | | | | $ | 149.20 | | | | | 7/27/2030(4) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | 339 | | | | | 911(7) | | | | | — | | | | $ | 69.80 | | | | | 8/16/2031(4) | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | — | | | | | 3,009(3) | | | | | — | | | | $ | 31.60 | | | | | 1/24/2032(4) | | | | | — | | | | | — | | | | | — | | | | | — | | |
Fiscal Year | | | Summary Compensation Table Total for CEO ($)(1) | | | Compensation Actually Paid to CEO ($)(2) | | | Average Summary Compensation Table Total for Non-CEO Named E xecutive Officers (“NEOs”) ($)(3) | | | Average Compensation Actually Paid to Non-CEO NEOs ($)(2)(3) | | | Value of Initial Fixed $100 Investment Based on: Total Shareholder Return ($)(4) | | | Net Income ($ millions) | | ||||||||||||||||||
2022 | | | | $ | 1,154,820 | | | | | $ | 650,042 | | | | | $ | 750,971 | | | | | $ | 379,204 | | | | | $ | 5.20 | | | | | $ | (33.78) | | |
2021 | | | | $ | 1,513,718 | | | | | $ | 997,784 | | | | | $ | 848,982 | | | | | $ | (584,865) | | | | | $ | 47.56 | | | | | $ | (25.41) | | |
Item and Value Added (Deducted) | | | 2022 | | | 2021 | | ||||||
For CEO: | | | | | | | | | | | | | |
Summary Compensation Table Total | | | | $ | 1,154,820 | | | | | $ | 1,513,718 | | |
- Summary Compensation Table “Option Awards” column value | | | | | (318,240) | | | | | | (799,886) | | |
+ year-end fair value of outstanding and unvested equity awards granted in the fiscal year | | | | | 47,863 | | | | | | 283,952 | | |
+/- change in fair value of outstanding and unvested equity awards granted in prior years | | | | | (163,254) | | | | | | 0 | | |
+ vest date fair value of equity awards granted in the covered year | | | | | 0 | | | | | | 0 | | |
+/- change in fair value of prior-year equity awards vested in the fiscal year | | | | | (71,147) | | | | | | 0 | | |
Compensation Actually Paid | | | | $ | 650,042 | | | | | $ | 997,784 | | |
For Non-CEO NEOs (Average): | | | | | | | | | | | | | |
Summary Compensation Table Total | | | | $ | 750,971 | | | | | $ | 848,982 | | |
- Summary Compensation Table “Option Awards” column value | | | | | (278,794) | | | | | | (350,387) | | |
+ year-end fair value of outstanding and unvested equity awards granted in the fiscal year | | | | | 22,790 | | | | | | 29,207 | | |
+/- change in fair value of outstanding and unvested equity awards granted in prior years | | | | | (86,743) | | | | | | (216,241) | | |
+ vest date fair value of equity awards granted in the covered year | | | | | 0 | | | | | | 0 | | |
+/- change in fair value of prior-year equity awards vested in the fiscal year | | | | | (29,020) | | | | | | (896,426) | | |
Compensation Actually Paid | | | | $ | 379,204 | | | | | $ | (584,865) | | |
| Total Shareholder Return | |
| Net Income | |
Name | | Cash Compensation(1) | | Option Grants(2) | | Stock Awards(3) | | Total | | | Cash Compensation(1) | | Option Grants(2) | | Stock Awards(3) | | Total | | ||||||||||||||||||||||||||||||||
Dov A. Goldstein, M.D. | | | $ | 55,000 | | | | $ | 90,380 | | | | $ | — | | | | $ | 145,380 | | | | | $ | 58,625 | | | | $ | 15,792 | | | | $ | — | | | | $ | 74,417 | | | ||||||||
Diego Miralles, M.D.(4) | | | $ | 23,803 | | | | $ | — | | | | $ | — | | | | $ | 23,803 | | | |||||||||||||||||||||||||||||
Eric J. Ende, M.D.(5) | | | $ | 28,125 | | | | $ | 335,792 | | | | $ | — | | | | $ | 363,917 | | | |||||||||||||||||||||||||||||
Franklyn G. Prendergast, M.D., Ph.D. | | | $ | 52,500 | | | | $ | 90,380 | | | | $ | — | | | | $ | 142,880 | | | | | $ | 52,500 | | | | $ | 15,792 | | | | $ | — | | | | $ | 68,292 | | | ||||||||
Eric I. Richman | | | $ | 45,590 | | | | $ | 90,380 | | | | $ | — | | | | $ | 135,970 | | | | | $ | 52,583 | | | | $ | 15,792 | | | | $ | — | | | | $ | 68,375 | | | ||||||||
Gerry J, McDougall(5) | | | $ | 16,997 | | | | $ | 90,380 | | | | $ | — | | | | $ | 107,377 | | | |||||||||||||||||||||||||||||
Gerald J. McDougall(8) | | | $ | 44,000 | | | | $ | 15,792 | | | | $ | — | | | | $ | 59,792 | | |
Name and Address of Beneficial Owner | | | Number of Shares Beneficially Owned | | | Percentage of Class (%)(1) | | ||||||
Dietrich Stephan, Ph.D., Director and Chief Executive Officer(2) | | | | | 4,636,743 | | | | | | 14.4% | | |
Greenlight Capital, Inc.(3) | | | | | 2,727,027 | | | | | | 8.5% | | |
Directors and Named Executive Officers(4) | | | | | | | | | | | | | |
Todd Branning, Chief Financial Officer(5) | | | | | 30,000 | | | | | | * | | |
William Mann, Ph.D., President and Chief Operating Officer(6) | | | | | 108,596 | | | | | | * | | |
Sandra Rojas-Caro, M.D., Head of Research & Development and Chief Medical Officer(7) | | | | | 87,500 | | | | | | * | | |
Dov A. Goldstein, M.D., Director(8) | | | | | 274,181 | | | | | | * | | |
Gerry J. McDougall, Director(9) | | | | | 40,274 | | | | | | * | | |
Franklyn G. Prendergast, M.D., Ph.D., Director(10) | | | | | 244,181 | | | | | | * | | |
Eric I. Richman, Director(11) | | | | | 289,141 | | | | | | * | | |
Eric Ende, Director | | | | | — | | | | | | — | | |
All current executive officers and directors as a group (nine persons)(12) | | | | | 5,710,616 | | | | | | 17.7% | | |
Name and Address of Beneficial Owner | | | Number of Shares Beneficially Owned | | | Percentage of Class (%)(1) | | ||||||
5% Stockholders | | | | | | | | | | | | | |
Dietrich A. Stephan, Ph.D., Director and Chief Executive Officer(2) | | | | | 250,206 | | | | | | 11.5% | | |
Greenlight Capital, Inc.(3) | | | | | 136,350 | | | | | | 6.3% | | |
Armistice Capital Master Fund Ltd.(4) | | | | | 5,671,052 | | | | | | 74.42% | | |
Other Directors and Named Executive Officers(5) | | | | | | | | | | | | | |
Todd P. Branning, Chief Financial Officer(6) | | | | | 4,210 | | | | | | * | | |
Dov A. Goldstein, M.D., Chairperson (7) | | | | | 14,879 | | | | | | * | | |
Gerald J. McDougall, Director(8) | | | | | 4,153 | | | | | | * | | |
Franklyn G. Prendergast, M.D., Ph.D., Director(9) | | | | | 13,379 | | | | | | * | | |
Eric I. Richman, Director(10) | | | | | 15,626 | | | | | | * | | |
All current executive officers and directors as a group (six persons)(11) | | | | | 302,453 | | | | | | 13.9% | | |